Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection
2007
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Osteoporosis
2019 Standout
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients
2000
Reviews Of Anti‐infective Agents: Anidulafungin: A Novel Echinocandin
2006
Sexual dimorphism of humoral immunity with human vaccines
2008
Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)
2003
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
2008
A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme Disease
1998
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Hepatitis B virus infection
2009 Standout
Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies
2005
Anidulafungin: an echinocandin antifungal
2004
Anidulafungin: A new echinocandin with a novel profile
2005
Hepatitis B vaccines
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
2014
Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
1998 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Neonatal and early life vaccinology
2001
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures
2008
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
2011
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
2012
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good
2011
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
2001
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Clinical management of Staphylococcus aureus bacteraemia
2011
Sex differences in immune responses
2016 Standout
Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureus
2007
Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
2011
Quality of Life Outcomes for Depressed and Nondepressed Older Adults in Community Long-Term Care
2010
Lyme borreliosis
2011 Standout
Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
2014
Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
2012
Immunisation in the current management of cystic fibrosis patients
2005
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Association Between Palliative Care and Patient and Caregiver Outcomes
2016 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Investment bankers and IPO pricing: does prospectus information matter?
2004
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach
2011
Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection
2004
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
Board composition, share ownership, and ‘underpricing’ of U.K. IPO firms
2002
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents
2005
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Signaling Firm Value through Board Structure: An Investigation of Initial Public Offerings
2001
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections
2006
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Investigational treatments for postoperative surgical site infections
2007
Invasive Candidiasis
2015 Standout
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
2018
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Effects of a program for coordinated care of advanced illness on patients, surrogates, and healthcare costs: a randomized trial.
2006
Boards of Directors and Firm Performance: Integrating Agency and Resource Dependence Perspectives
2003 Standout
Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection
2012
Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial
2013
Signaling Theory: A Review and Assessment
2010 Standout
How Does Human Resource Management Influence Organizational Outcomes? A Meta-analytic Investigation of Mediating Mechanisms
2012 Standout
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Echinocandins: role in antifungal therapy, 2005
2005
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
The effect of human resource management practices on Japanese MNC subsidiary performance: a partial mediating model
2003
Salmon Calcitonin Use and Associated Cancer Risk
2013
The Influence of Top Management Team Heterogeneity on the Capital Raised through an Initial Public Offering
2008
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
Comparison of Dalbavancin MIC Values Determined by Etest (AB BIODISK) and Reference Dilution Methods Using Gram-Positive Organisms
2006
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
2003 StandoutNobel
Works of David Krause being referenced
Does salmon calcitonin cause cancer? A review and meta-analysis
2015
Principles for Assessing Disease Management Outcomes
2004
Economic Effectiveness of Disease Management Programs: A Meta-Analysis
2005
Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates
1994
Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease
1995
Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules
1997
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants
2004
Safety And Immunogenicity Of An Inactivated Hepatitis A Vaccine In Preschool Children
1995
Anidulafungin Does Not Require Dosage Adjustment in Subjects With Varying Degrees of Hepatic or Renal Impairment
2007
Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections
2005
Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents
1995
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
1998
Immunogenicity Of An Inactivated Hepatitis A Vaccine In Alaska Native Children And Native And Non-Native Adults
1995
Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal
2004
Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine
2005
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
2012
Going public: The impact of insiders' holdings on the price of initial public offerings
1989
Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals
1999
Lack of Pharmacokinetic Interaction Between Anidulafungin and Tacrolimus
2007